Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

Subgroup analysis based on prior treatment from the Phase 3 allele study of tabelecleucel for epstein-barr virus-driven post-transplant lymphoproliferative disease

Sarah Nikiforow, Kris Mahadeo, Sridhar Chaganti, Amer Beitinjaneh, Sylvain Choquet, Daan Dierickx, Armin Ghobadi, Roberta Valenti, Anke Friedetzky, Sandrine Roye, Ran Reshef, Susan Prockop, Robert Baiocchi

Blood (2025) 146 (Supplement 1): 1934.

https://doi.org/10.1182/blood-2025-1934

Published: 2025

Journal Articles

Subgroup analysis in pediatric patients from the Phase 3 study of tabelecleucel for allogeneic or solid organ transplant recipients with Epstein–Barr virus-driven post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE)

Sonali Chaudhury, Ran Reshef, Sarah Nikiforow, Diane M. George, Neena Kapoor, Michael Kent, Joerg Krueger, Theresa Cole, Pere Barba, Eduardo Olavarria, Roberta Valenti, Anke Friedetzky, Sandrine Roye, Susan Prockop

Blood (2025) 146 (Supplement 1): 5488.

https://doi.org/10.1182/blood-2025-5488

Published: 2025